139 related articles for article (PubMed ID: 16880702)
1. [Pharmacological and clinical profile of finasteride (PROPECIA)].
Fukuzumi H; Ikeda T; Narita H; Takubo T; Matsuda T; Taniguchi T
Nihon Yakurigaku Zasshi; 2006 Jun; 127(6):495-502. PubMed ID: 16880702
[No Abstract] [Full Text] [Related]
2. Propecia dosages.
Thiboutot D
Arch Dermatol; 1999 Nov; 135(11):1417. PubMed ID: 10566850
[No Abstract] [Full Text] [Related]
3. [5alpha-dihydrotestosterone (DHT)].
Komiya A; Suzuki H; Ichikawa T
Nihon Rinsho; 2005 Aug; 63 Suppl 8():452-6. PubMed ID: 16149549
[No Abstract] [Full Text] [Related]
4. [Therapy of androgenetic alopecia with finasteride. What must be considered in consultation and drug prescribing].
Wolff H; Kunte C
MMW Fortschr Med; 1999 Sep; 141(37):38-40. PubMed ID: 10897972
[TBL] [Abstract][Full Text] [Related]
5. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
Bartsch G; Rittmaster RS; Klocker H
Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
[TBL] [Abstract][Full Text] [Related]
6. Changes of metabolic profile in men treated for androgenetic alopecia with 1 mg finasteride.
Duskova M; Hill M; Starka L
Endocr Regul; 2010 Jan; 44(1):3-8. PubMed ID: 20151762
[TBL] [Abstract][Full Text] [Related]
7. In vivo time-dependent inhibition of human steroid 5 alpha-reductase by finasteride.
Tian G
J Pharm Sci; 1996 Jan; 85(1):106-11. PubMed ID: 8926574
[TBL] [Abstract][Full Text] [Related]
8. Propecia and Rogaine Extra Strength for alopecia.
Med Lett Drugs Ther; 1998 Feb; 40(1021):25-7. PubMed ID: 9505960
[No Abstract] [Full Text] [Related]
9. Saturable binding of finasteride to steroid 5alpha-reductase as determinant of nonlinear pharmacokinetics.
Suzuki R; Satoh H; Ohtani H; Hori S; Sawada Y
Drug Metab Pharmacokinet; 2010; 25(2):208-13. PubMed ID: 20460827
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat.
Stuart JD; Lee FW; Simpson Noel D; Kadwell SH; Overton LK; Hoffman CR; Kost TA; Tippin TK; Yeager RL; Batchelor KW; Bramson HN
Biochem Pharmacol; 2001 Oct; 62(7):933-42. PubMed ID: 11543729
[TBL] [Abstract][Full Text] [Related]
11. 5 alpha-metabolism in finasteride-treated subjects and male pseudohermaphrodites with inherited 5 alpha-reductase deficiency. A review.
Imperato-McGinley J
Eur Urol; 1991; 20 Suppl 1():78-81. PubMed ID: 1722167
[TBL] [Abstract][Full Text] [Related]
12. Plasma androsterone/epiandrosterone sulfates as markers of 5 alpha-reductase activity: effect of finasteride in normal men.
Lewis JG; George PM; Elder PA
Steroids; 1997; 62(8-9):632-5. PubMed ID: 9292937
[TBL] [Abstract][Full Text] [Related]
13. A putative 5 alpha-reductase inhibitor demasculinizes portions of the zebra finch song system.
Grisham W; Tam A; Greco CM; Schlinger BA; Arnold AP
Brain Res; 1997 Mar; 750(1-2):122-8. PubMed ID: 9098536
[TBL] [Abstract][Full Text] [Related]
14. 5 alpha-reductase and finasteride in pattern alopecia and acne.
Burkhart CG; Burkhart CN
J Drugs Dermatol; 2004; 3(4):363-4. PubMed ID: 15303779
[No Abstract] [Full Text] [Related]
15. Androgens and alopecia.
Kaufman KD
Mol Cell Endocrinol; 2002 Dec; 198(1-2):89-95. PubMed ID: 12573818
[TBL] [Abstract][Full Text] [Related]
16. Finasteride is the main inhibitor of 5alpha-reductase activity in microdissected dermal papillae of human hair follicles.
Hoffmann R; Happle R
Arch Dermatol Res; 1999; 291(2-3):100-3. PubMed ID: 10195397
[No Abstract] [Full Text] [Related]
17. Comparative study of human steroid 5alpha-reductase isoforms in prostate and female breast skin tissues: sensitivity to inhibition by finasteride and epristeride.
Ranjan M; Diffley P; Stephen G; Price D; Walton TJ; Newton RP
Life Sci; 2002 May; 71(2):115-26. PubMed ID: 12031682
[TBL] [Abstract][Full Text] [Related]
18. Effects of the anti-androgen finasteride on the modulatory actions of oestradiol on androgen metabolism by human gingival fibroblasts.
Tilakaratne A; Soory M
Arch Oral Biol; 2001 Feb; 46(2):109-15. PubMed ID: 11163318
[TBL] [Abstract][Full Text] [Related]
19. C19 and C21 5 beta/5 alpha metabolite ratios in subjects treated with the 5 alpha-reductase inhibitor finasteride: comparison of male pseudohermaphrodites with inherited 5 alpha-reductase deficiency.
Imperato-McGinley J; Shackleton C; Orlic S; Stoner E
J Clin Endocrinol Metab; 1990 Mar; 70(3):777-82. PubMed ID: 1689740
[TBL] [Abstract][Full Text] [Related]
20. [Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?].
Spinucci G; Pasquali R
Clin Ter; 1996 Jun; 147(6):305-15. PubMed ID: 8925640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
